Anteris Technologies Global Corp. has announced a private placement agreement with Medtronic plc, under which Medtronic will purchase up to $90 million of Anteris common stock through a wholly owned subsidiary. The shares will be sold at the same price as the company's concurrent public offering and will represent between 16.0% and 19.99% of the total shares outstanding after the offering. The private placement is contingent on the completion of the public offering and will be conducted under an exemption from registration under the Securities Act of 1933. Wells Fargo Securities will act as the sole placement agent for this transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anteris Technologies Global Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9629094) on January 20, 2026, and is solely responsible for the information contained therein.